BML Capital Management, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
BML Capital Management, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,039,172
-33.0%
781,292
-8.1%
1.87%
-31.6%
Q2 2023$3,043,000
+2.9%
850,000
-37.3%
2.74%
+7.1%
Q1 2023$2,955,9171,355,9252.56%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders